ATE522498T1 - Sedative hypnotisch wirkende verbindungen mit kurzer wirkungsdauer zur anaesthesie und sedierung - Google Patents
Sedative hypnotisch wirkende verbindungen mit kurzer wirkungsdauer zur anaesthesie und sedierungInfo
- Publication number
- ATE522498T1 ATE522498T1 AT03799743T AT03799743T ATE522498T1 AT E522498 T1 ATE522498 T1 AT E522498T1 AT 03799743 T AT03799743 T AT 03799743T AT 03799743 T AT03799743 T AT 03799743T AT E522498 T1 ATE522498 T1 AT E522498T1
- Authority
- AT
- Austria
- Prior art keywords
- sedation
- anesthesia
- short
- sedative hypnotic
- acting sedative
- Prior art date
Links
- 206010039897 Sedation Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000036280 sedation Effects 0.000 title abstract 2
- 206010002091 Anaesthesia Diseases 0.000 title 1
- 230000037005 anaesthesia Effects 0.000 title 1
- 230000004799 sedative–hypnotic effect Effects 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 238000002695 general anesthesia Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35138502P | 2002-01-25 | 2002-01-25 | |
| US37921902P | 2002-05-09 | 2002-05-09 | |
| PCT/US2003/002227 WO2004037750A2 (en) | 2002-01-25 | 2003-01-24 | Short-acting sedative hypnotic agents for anesthesia and sedation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE522498T1 true ATE522498T1 (de) | 2011-09-15 |
Family
ID=32179539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03799743T ATE522498T1 (de) | 2002-01-25 | 2003-01-24 | Sedative hypnotisch wirkende verbindungen mit kurzer wirkungsdauer zur anaesthesie und sedierung |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US6887866B2 (de) |
| EP (1) | EP1509492B1 (de) |
| KR (2) | KR100925790B1 (de) |
| CN (1) | CN1257152C (de) |
| AT (1) | ATE522498T1 (de) |
| AU (1) | AU2003299453B2 (de) |
| BR (1) | BRPI0307017B1 (de) |
| CA (1) | CA2474262C (de) |
| CY (1) | CY1112487T1 (de) |
| DK (1) | DK1509492T3 (de) |
| ES (1) | ES2371461T3 (de) |
| IL (3) | IL162862A0 (de) |
| MX (1) | MXPA04007023A (de) |
| NZ (1) | NZ534012A (de) |
| PL (1) | PL207038B1 (de) |
| PT (1) | PT1509492E (de) |
| RU (1) | RU2315037C2 (de) |
| SI (1) | SI1509492T1 (de) |
| TW (1) | TWI290466B (de) |
| WO (1) | WO2004037750A2 (de) |
| ZA (1) | ZA200405561B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL207038B1 (pl) * | 2002-01-25 | 2010-10-29 | Theravance | Podstawione pochodne kwasu fenylooctowego, związek pośredni, kompozycja farmaceutyczna zawierająca te pochodne oraz ich zastosowanie |
| PL1648413T3 (pl) * | 2003-07-23 | 2010-03-31 | Theravance Inc | Kompozycje farmaceutyczne zawierające jako składnik czynny krótko działający środek uspokajający i usypiający |
| US8329744B2 (en) * | 2005-11-02 | 2012-12-11 | Relmada Therapeutics, Inc. | Methods of preventing the serotonin syndrome and compositions for use thereof |
| US20090082466A1 (en) * | 2006-01-27 | 2009-03-26 | Najib Babul | Abuse Resistant and Extended Release Formulations and Method of Use Thereof |
| US9125833B2 (en) * | 2005-11-02 | 2015-09-08 | Relmada Therapeutics, Inc. | Multimodal abuse resistant and extended release opioid formulations |
| US20090286832A1 (en) * | 2008-05-15 | 2009-11-19 | Kiichiro Nabeta | Narcotic emulsion formulations for treatment of surgical pain |
| ES2742728T3 (es) | 2009-07-22 | 2020-02-17 | PureTech Health LLC | Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico |
| CN102190580A (zh) * | 2010-03-12 | 2011-09-21 | 重庆欣欣向荣精细化工有限公司 | 乙基香兰素合成中间体3-乙氧基-4-羟基扁桃酸的制备方法 |
| KR20130062282A (ko) * | 2010-05-13 | 2013-06-12 | 아스트라제네카 아베 | 진정 수면제의 주사가능한 에멀젼 |
| CN102863353A (zh) * | 2012-07-27 | 2013-01-09 | 华中科技大学 | 取代的苯基乙酸酯化合物及其应用 |
| CN103450009B (zh) * | 2013-09-02 | 2015-04-22 | 江苏宝众宝达药业有限公司 | 一种对羟基苯乙酸的制备方法 |
| CN105272871B (zh) * | 2014-06-20 | 2017-08-22 | 济南蓝丹医药科技有限公司 | 具有提高的药代动力学性能和麻醉性能的苯基乙酸酯类化合物 |
| CN104211615B (zh) * | 2014-08-12 | 2017-11-03 | 武汉珈瑜科技有限公司 | 苯基氟取代的苯乙酸酯化合物及其应用 |
| CN104262292B (zh) * | 2014-09-08 | 2019-02-22 | 武汉珈瑜科技有限公司 | 苯乙酸酯化合物及其应用 |
| CN104622806B (zh) * | 2015-02-04 | 2018-03-16 | 北京蓝丹医药科技有限公司 | 一种丙泮尼地药物组合物及其制备方法 |
| CN104887628A (zh) * | 2015-06-02 | 2015-09-09 | 北京蓝丹医药科技有限公司 | 一种稳定的苯基乙酸酯类药物脂肪乳 |
| CN104887629A (zh) * | 2015-06-09 | 2015-09-09 | 北京蓝丹医药科技有限公司 | 一种稳定的丙泮尼地脂肪乳 |
| PT3856182T (pt) * | 2018-09-28 | 2026-03-10 | Karuna Therapeutics Inc | Composições e métodos para o tratamento de perturbações melhoradas pela ativação dos recetores muscarínicos |
| US12630495B2 (en) | 2020-04-27 | 2026-05-19 | Symrise Ag | Method for producing esters of homovanillic acid |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3086976A (en) | 1959-01-23 | 1963-04-23 | Egyt Gyogyszervegyeszeti Gyar | Benzoic acid derivatives and process for producing same |
| DE1134981B (de) * | 1960-05-06 | 1962-08-23 | Bayer Ag | Verfahren zur Herstellung von N-substituierten 3-Methoxy-4-carbamidomethoxyphenylessigsaeurealkyl- und alkenylestern |
| US3086978A (en) * | 1960-05-06 | 1963-04-23 | Bayer Ag | 3-methoxy-4-carbamidomethoxy-phenylacetic acid esters |
| US3088978A (en) * | 1960-09-12 | 1963-05-07 | Walter H Brunner | Catalytic hydrogenation of 2, 4-dinitrophenylamines |
| NL284933A (de) | 1961-10-31 | |||
| NL286944A (de) | 1961-12-20 | |||
| US3510559A (en) * | 1964-01-10 | 1970-05-05 | Geigy Chem Corp | 2-alkoxyphenoxy-acetamides as anesthetics agents |
| CH432494A (de) | 1964-01-10 | 1967-03-31 | Geigy Ag J R | Verfahren zur Herstellung neuer Aryloxyessigsäureamide |
| US3511877A (en) * | 1964-02-11 | 1970-05-12 | Geigy Chem Corp | Phenoxyacetic acid diethylamides |
| DE1249851B (de) * | 1964-02-11 | 1967-09-14 | J R Geigy A G Basel (Schweiz) | Morel Ariesheim (Schweiz) j Verfahren zur Herstellung neuer Phenoxyessigsäure amide |
| DE1518819B1 (de) | 1965-04-03 | 1969-12-04 | Basf Ag | Loesungsvermittler fuer pharmazeutische Zwecke |
| US3484537A (en) | 1969-03-03 | 1969-12-16 | American Mach & Foundry | Photocontrol enclosure and support |
| US4798846A (en) * | 1974-03-28 | 1989-01-17 | Imperial Chemical Industries Plc | Pharmaceutical compositions |
| GB1571395A (en) | 1976-07-12 | 1980-07-16 | Delmar Chem | Substituted phenyl acetic acid esters |
| JPS5699440A (en) * | 1980-01-11 | 1981-08-10 | Ube Ind Ltd | Preparation of 3-alkoxy-4-hydroxyphenylacetic acid |
| ATE11736T1 (de) * | 1980-12-23 | 1985-02-15 | Dr. Franz Koehler Chemie Gmbh | Protektive loesung fuer herz und niere und verfahren zu deren herstellung. |
| JPS6038343A (ja) * | 1983-08-11 | 1985-02-27 | Mitsubishi Petrochem Co Ltd | フエニル酢酸誘導体の製造方法 |
| DE3339236A1 (de) * | 1983-10-28 | 1985-05-09 | Bayer Ag | Arzneimittelzubereitung |
| US4918092A (en) * | 1983-12-21 | 1990-04-17 | Merck Frosst Canada, Inc. | Leukotriene antagonists |
| IT1204778B (it) * | 1986-02-04 | 1989-03-10 | Mazzarella Basilio | Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale |
| US5092838A (en) * | 1989-11-30 | 1992-03-03 | Baxter International Inc. | Histidine buffered peritoneal dialysis solution |
| US4981092A (en) * | 1989-11-17 | 1991-01-01 | R. G. Barry Corporation | Fabric clamping device for embroidery machines |
| US5242944A (en) * | 1991-06-20 | 1993-09-07 | Korea Research Institute Of Chemical Technology | Phenylacetamide derivatives and pharmaceutical compositions thereof |
| GB9405593D0 (en) | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
| US20020173547A1 (en) * | 1994-03-22 | 2002-11-21 | Jones Christopher Buchan | Pharmaceuticals compositions |
| ZA962214B (en) | 1995-04-10 | 1996-10-07 | Farmarc Nederland Bv | Pharmaceutical composition |
| JPH0926544A (ja) * | 1995-07-10 | 1997-01-28 | Nikon Corp | 顕微鏡用中間鏡筒 |
| US6281175B1 (en) * | 1997-09-23 | 2001-08-28 | Scimed Life Systems, Inc. | Medical emulsion for lubrication and delivery of drugs |
| ATE370726T1 (de) * | 1998-02-10 | 2007-09-15 | Sicor Inc | Propofolhaltiges arzneimittel enthaltend sulfite |
| US6028108A (en) * | 1998-10-22 | 2000-02-22 | America Home Products Corporation | Propofol composition comprising pentetate |
| US6140373A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
| US6140374A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
| US6177477B1 (en) * | 1999-03-24 | 2001-01-23 | American Home Products Corporation | Propofol formulation containing TRIS |
| WO2001097779A2 (en) * | 2000-06-16 | 2001-12-27 | Rtp Pharma Inc. | Improved injectable dispersions of propofol |
| PL207038B1 (pl) * | 2002-01-25 | 2010-10-29 | Theravance | Podstawione pochodne kwasu fenylooctowego, związek pośredni, kompozycja farmaceutyczna zawierająca te pochodne oraz ich zastosowanie |
-
2003
- 2003-01-24 PL PL373420A patent/PL207038B1/pl unknown
- 2003-01-24 IL IL16286203A patent/IL162862A0/xx unknown
- 2003-01-24 EP EP03799743A patent/EP1509492B1/de not_active Expired - Lifetime
- 2003-01-24 CN CNB038026910A patent/CN1257152C/zh not_active Expired - Fee Related
- 2003-01-24 AU AU2003299453A patent/AU2003299453B2/en not_active Ceased
- 2003-01-24 CA CA2474262A patent/CA2474262C/en not_active Expired - Fee Related
- 2003-01-24 ES ES03799743T patent/ES2371461T3/es not_active Expired - Lifetime
- 2003-01-24 SI SI200332070T patent/SI1509492T1/sl unknown
- 2003-01-24 PT PT03799743T patent/PT1509492E/pt unknown
- 2003-01-24 KR KR1020047011420A patent/KR100925790B1/ko not_active Expired - Fee Related
- 2003-01-24 DK DK03799743.4T patent/DK1509492T3/da active
- 2003-01-24 NZ NZ534012A patent/NZ534012A/en not_active IP Right Cessation
- 2003-01-24 RU RU2004125854/04A patent/RU2315037C2/ru not_active IP Right Cessation
- 2003-01-24 AT AT03799743T patent/ATE522498T1/de active
- 2003-01-24 US US10/350,624 patent/US6887866B2/en not_active Expired - Fee Related
- 2003-01-24 WO PCT/US2003/002227 patent/WO2004037750A2/en not_active Ceased
- 2003-01-24 BR BRPI0307017A patent/BRPI0307017B1/pt not_active IP Right Cessation
- 2003-01-24 KR KR1020087016567A patent/KR100951846B1/ko not_active Expired - Fee Related
- 2003-05-27 TW TW092114270A patent/TWI290466B/zh not_active IP Right Cessation
-
2004
- 2004-07-05 IL IL162862A patent/IL162862A/en not_active IP Right Cessation
- 2004-07-13 ZA ZA2004/05561A patent/ZA200405561B/en unknown
- 2004-07-20 MX MXPA04007023A patent/MXPA04007023A/es active IP Right Grant
- 2004-11-03 US US10/980,067 patent/US7015346B2/en not_active Expired - Fee Related
-
2006
- 2006-01-13 US US11/332,409 patent/US7514425B2/en not_active Expired - Fee Related
-
2009
- 2009-03-10 US US12/400,942 patent/US7939689B2/en not_active Expired - Fee Related
- 2009-10-19 IL IL201639A patent/IL201639A/en not_active IP Right Cessation
-
2011
- 2011-11-07 CY CY20111101067T patent/CY1112487T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112487T1 (el) | Βραχειας-δρασης ηρεμιστικοι υπνωτικοι παραγοντες για αναισθησια και καταστολη | |
| ATE269295T1 (de) | Btk inhibitoren und verfahren zur identifizierung und verwendung | |
| CR9428A (es) | Metodos para el tratamiento y la prevencion de fibrosis | |
| ECSP077401A (es) | Medicamentos que contienen compuestos de carbonilo y su uso | |
| CY1112862T1 (el) | Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα | |
| UA89734C2 (en) | ANTAGONISTS of muscarinic acetylcholine receptors | |
| ECSP088440A (es) | Imidazopirazinas como inhibidores de proteinquinasa | |
| CY1110225T1 (el) | Κυκλικοι αναστολεις πρωτεϊνικης τυροσινικης κινασης | |
| DE60007095D1 (de) | Calanolide zur hemmung von btk | |
| ATE407998T1 (de) | Reinigungsmittel | |
| ATE498395T1 (de) | Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung | |
| DE502004002571D1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
| PL1877390T3 (pl) | Związki benzizoksazolopiperazynowe i sposoby ich stosowania | |
| ATE471324T1 (de) | Triazolophthalazine | |
| ECSP066763A (es) | Pirazolopirimidinas novedosas como inhibidores de quinasa ciclina-dependientes | |
| EP1740183B8 (de) | Neue verwendung von pde5-hemmern | |
| SE0301650D0 (sv) | Novel compounds | |
| DE602004032465D1 (de) | Referenzstandard zur charakterisierung von rosuvastatin | |
| CY1109657T1 (el) | Φαρμακευτικες συνθεσεις ηρεμιστικου υπνωτικου μεσου ταχειας δρασης | |
| SE0302361D0 (sv) | Inhibering av upptagning av monoamin | |
| NO20053903D0 (no) | Nukleotidlipidesterderivater. | |
| CL2004001041A1 (es) | Composicion farmaceutica que comprende un analeptico y un antidepresivo; uso en el tratamientonto de trastornos depresivos. | |
| UY27820A1 (es) | Acetamidas y benzamidas que son útiles en el tratamiento de disfunciones sexuales | |
| CY1114739T1 (el) | Μεθοδοι και συνθεσεις για ανιχνευση αυτοανοσων διαταραχων | |
| TW200635902A (en) | Methods and formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1509492 Country of ref document: EP |